EXAS: Exact Sciences Amount of Cash per Share

Corporate emblem and logo of Exact Sciences Inc. (EXAS)

Optimizing biosample delivery reduces costs, strengthening the credit profile of Exact Sciences (EXAS). The cash per share metric demonstrates stability, with the latest value recorded as 5.01. Liquidity is supported by laboratory robotization and the experienced management's effective lobbying to integrate tests into government programs. This strategy provides the company with a reliable financial reserve and high operational efficiency.

Cologuard (EXAS) Cash per Share: for the period 07/04/2022 - 04/04/2026

Comprehensive metric breakdowns and analytics for Exact Sciences Inc. (EXAS)

- share price and consensus valuation forecast:
- market capitalization information:
- cash position and cash flow details:
Comprehensive company analysis:Cologuard EXAS
Manufactured product of Cologuard

Cash per share determines the issuer's actual liquid basis, measuring the volume of available capital per security to assess financial stability. Analyzing the cash per share structure allows for portfolio stress-testing, confirming the ability of Exact Sciences (EXAS) to fund costly R&D and maintain market positions amid fierce competition in the early cancer detection sector.